The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Short Bowel Syndrome (SBS) Drugs Revenue 1.5 Market Analysis by Type 1.5.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Glucagon-Like Peptide-2 (GLP-2) 1.5.3 Growth Hormone 1.5.4 Glutamine 1.5.5 Other 1.6 Market by Application 1.6.1 Global Short Bowel Syndrome (SBS) Drugs Market Share by Application: 2021-2026 1.6.2 Hospitals 1.6.3 Clinics 1.6.4 Retail Pharmacies 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Short Bowel Syndrome (SBS) Drugs Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Short Bowel Syndrome (SBS) Drugs Market Players Profiles 3.1 Merck 3.1.1 Merck Company Profile 3.1.2 Merck Short Bowel Syndrome (SBS) Drugs Product Specification 3.1.3 Merck Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Sancilio Pharmaceuticals 3.2.1 Sancilio Pharmaceuticals Company Profile 3.2.2 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Specification 3.2.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Ardelyx 3.3.1 Ardelyx Company Profile 3.3.2 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Specification 3.3.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Takeda 3.4.1 Takeda Company Profile 3.4.2 Takeda Short Bowel Syndrome (SBS) Drugs Product Specification 3.4.3 Takeda Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 OxThera 3.5.1 OxThera Company Profile 3.5.2 OxThera Short Bowel Syndrome (SBS) Drugs Product Specification 3.5.3 OxThera Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Emmaus Medical 3.6.1 Emmaus Medical Company Profile 3.6.2 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Specification 3.6.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Nutrinia 3.7.1 Nutrinia Company Profile 3.7.2 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Specification 3.7.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Naia Pharmaceuticals 3.8.1 Naia Pharmaceuticals Company Profile 3.8.2 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Specification 3.8.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Zealand Pharma 3.9.1 Zealand Pharma Company Profile 3.9.2 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Specification 3.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Short Bowel Syndrome (SBS) Drugs Market Competition by Market Players 4.1 Global Short Bowel Syndrome (SBS) Drugs Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Market Players (2015-2020) 4.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Market Players (2015-2020) 5 Global Short Bowel Syndrome (SBS) Drugs Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.1.2 Short Bowel Syndrome (SBS) Drugs Key Players in North America (2015-2020) 5.1.3 North America Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.1.4 North America Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.2.2 Short Bowel Syndrome (SBS) Drugs Key Players in East Asia (2015-2020) 5.2.3 East Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.2.4 East Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.3.2 Short Bowel Syndrome (SBS) Drugs Key Players in Europe (2015-2020) 5.3.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.3.4 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.4.2 Short Bowel Syndrome (SBS) Drugs Key Players in South Asia (2015-2020) 5.4.3 South Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.4.4 South Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.5.2 Short Bowel Syndrome (SBS) Drugs Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.5.4 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.6.2 Short Bowel Syndrome (SBS) Drugs Key Players in Middle East (2015-2020) 5.6.3 Middle East Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.6.4 Middle East Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.7.2 Short Bowel Syndrome (SBS) Drugs Key Players in Africa (2015-2020) 5.7.3 Africa Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.7.4 Africa Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.8.2 Short Bowel Syndrome (SBS) Drugs Key Players in Oceania (2015-2020) 5.8.3 Oceania Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.8.4 Oceania Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.9.2 Short Bowel Syndrome (SBS) Drugs Key Players in South America (2015-2020) 5.9.3 South America Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.9.4 South America Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Short Bowel Syndrome (SBS) Drugs Market Size (2015-2020) 5.10.2 Short Bowel Syndrome (SBS) Drugs Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Short Bowel Syndrome (SBS) Drugs Market Size by Type (2015-2020) 5.10.4 Rest of the World Short Bowel Syndrome (SBS) Drugs Market Size by Application (2015-2020) 6 Global Short Bowel Syndrome (SBS) Drugs Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Short Bowel Syndrome (SBS) Drugs Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Short Bowel Syndrome (SBS) Drugs Consumption by Countries 7 Global Short Bowel Syndrome (SBS) Drugs Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Short Bowel Syndrome (SBS) Drugs (2021-2026) 7.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs (2021-2026) 7.3 Global Forecasted Price of Short Bowel Syndrome (SBS) Drugs (2021-2026) 7.4 Global Forecasted Production of Short Bowel Syndrome (SBS) Drugs by Region (2021-2026) 7.4.1 North America Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.3 Europe Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.7 Africa Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.9 South America Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Short Bowel Syndrome (SBS) Drugs Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Application (2021-2026) 8 Global Short Bowel Syndrome (SBS) Drugs Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.2 East Asia Market Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.3 Europe Market Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Countriy 8.4 South Asia Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.5 Southeast Asia Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.6 Middle East Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.7 Africa Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.8 Oceania Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.9 South America Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 8.10 Rest of the world Forecasted Consumption of Short Bowel Syndrome (SBS) Drugs by Country 9 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2026) 9.1 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size by Type (2015-2020) 9.2 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Type (2021-2026) 10 Global Short Bowel Syndrome (SBS) Drugs Consumption by Application (2015-2026) 10.1 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size by Application (2015-2020) 10.2 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Application (2021-2026) 11 Global Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Analysis 11.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs 12 Global Short Bowel Syndrome (SBS) Drugs Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Short Bowel Syndrome (SBS) Drugs Distributors List 12.3 Short Bowel Syndrome (SBS) Drugs Customers 12.4 Short Bowel Syndrome (SBS) Drugs Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 138 |
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 145 |
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 105 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Consumer Goods and Retail | Pages : 116 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 221 |
We will be happy to help you find what you need. Please call us or write to us: